Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lappin

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
The American Journal on Addictions|August 19, 2021
Cognitive improvement among abstinent methamphetamine users: A 2-year prospective longitudinal studyTong-Yu Wang, Teng-Teng Fan, Julia M Lappin, et al.
Schizophrenia Research|January 12, 2007
Insight in individuals with an At Risk Mental StateJulia M Lappin, Kevin D Morgan, Lucia R Valmaggia, et al.
Applied and Environmental Microbiology|August 30, 2001
Effect of challenge temperature and solute type on heat tolerance of Salmonella serovars at low water activityK L Mattick, F Jørgensen, P Wang, et al.
The Australian and New Zealand Journal of Psychiatry|August 3, 2022
Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage studyPreeyaporn Srasuebkul, Adrian R Walker, Rachael C Cvejic, et al.
Drug Safety|July 15, 2019
Multimodal Analysis of FDA Drug Safety Communications: Lessons from ZolpidemAaron S Kesselheim, Michael S Sinha, Eric G Campbell, et al.
Frontiers in Psychiatry|October 30, 2018
Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic SymptomsMeng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, et al.
Journal of Translational Medicine|September 5, 2020
Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AMLJames S Smith, Katrina M Lappin, Stephanie G Craig, et al.
Eclinicalmedicine|December 14, 2019
Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysisRebecca McKetin, Janni Leung, Emily Stockings, et al.
Drug Safety|March 2, 2017
Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative StudyAaron S Kesselheim, Sarah A McGraw, Sara Z Dejene, et al.
The British Journal of Psychiatry. Supplement|January 19, 2008
Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosisJulia M Lappin, Paola Dazzan, Kevin Morgan, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
The American Journal on Addictions|August 19, 2021
Cognitive improvement among abstinent methamphetamine users: A 2-year prospective longitudinal studyTong-Yu Wang, Teng-Teng Fan, Julia M Lappin, et al.
Schizophrenia Research|January 12, 2007
Insight in individuals with an At Risk Mental StateJulia M Lappin, Kevin D Morgan, Lucia R Valmaggia, et al.
Applied and Environmental Microbiology|August 30, 2001
Effect of challenge temperature and solute type on heat tolerance of Salmonella serovars at low water activityK L Mattick, F Jørgensen, P Wang, et al.
The Australian and New Zealand Journal of Psychiatry|August 3, 2022
Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage studyPreeyaporn Srasuebkul, Adrian R Walker, Rachael C Cvejic, et al.
Drug Safety|July 15, 2019
Multimodal Analysis of FDA Drug Safety Communications: Lessons from ZolpidemAaron S Kesselheim, Michael S Sinha, Eric G Campbell, et al.
Frontiers in Psychiatry|October 30, 2018
Epidemiological Characteristics and Risk Factors of Methamphetamine-Associated Psychotic SymptomsMeng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, et al.
Journal of Translational Medicine|September 5, 2020
Chronic loss of STAG2 leads to altered chromatin structure contributing to de-regulated transcription in AMLJames S Smith, Katrina M Lappin, Stephanie G Craig, et al.
Eclinicalmedicine|December 14, 2019
Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysisRebecca McKetin, Janni Leung, Emily Stockings, et al.
Drug Safety|March 2, 2017
Patient and Physician Perceptions of Drug Safety Information for Sleep Aids: A Qualitative StudyAaron S Kesselheim, Sarah A McGraw, Sara Z Dejene, et al.
The British Journal of Psychiatry. Supplement|January 19, 2008
Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosisJulia M Lappin, Paola Dazzan, Kevin Morgan, et al.
Pageof 15